Year 2016 / Volume 108 / Number 11
Case Report
Mesalamine-induced myopericarditis - A case report

753-756

DOI: 10.17235/reed.2016.4016/2015

Sónia Bernardo, Samuel Raimundo Fernandes, Luís Araújo-Correia,

Abstract
Myopericarditis has occasionally been reported as a side effect of mesalamine in patients with inflammatory bowel disease. We present a 20-year-old woman with ulcerative colitis admitted with chest pain. After thorough investigation she was diagnosed with myopericarditis potentially related to mesalamine. There was complete clinical and laboratorial recovery following drug withdrawal. Although uncommon, the possibility of myopericarditis should be considered in patients with inflammatory bowel disease presenting with cardiac complaints. Early recognition can avoid potential life-threatening complications.
Share Button
New comment
Comments
No comments for this article
References
1. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003 Aug 14;349(7):684–90.
2. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World Journal of Gastroenterology. 2006. p. 4819–31.
3. Abid MA, Gitlin N. Pericarditis--an extraintestinal complication of inflammatory bowel disease. West J Med. 1990 Sep;153(3):314–5.
4. Freeman HJ, Salh B. Recurrent myopericarditis with extensive ulcerative colitis. The Canadian journal of cardiology. 2010. p. 549–50.
5. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study. Gastroenterology. 2005;129(3):827–36.
6. García-Morán S, Sáez-Royuela F, Pérez-Alvarez J-C, et al. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine. Inflamm Bowel Dis. 2006 Apr;12(4):334–5.
7. Waite RA, Malinowski JM. Possible mesalamine-induced pericarditis: case report and literature review. Pharmacotherapy. 2002. p. 391–4.
8. Gujral N, Friedenberg F, Friedenberg J, et al. Pleuropericarditis related to the use of mesalamine. Dig Dis Sci. 1996 Mar;41(3):624–6.
9. Sonu I, Wong R, Rothenberg ME. 5-ASA induced recurrent myopericarditis and cardiac tamponade in a patient with ulcerative colitis. Dig Dis Sci. 2013 Aug;58(8):2148–50.
10. Blum A, Shalabi R, Brofman T, et al. Cardiac manifestations of ulcerative colitis. Isr Med Assoc J. 2009 Dec;11(12):764–5.
11. Abu-Hijleh M, Evans S, Aswad B. Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature. Lung. 2010 Dec;188(6):505–10.
12. Vayre F, Vayre-Oundjian L, Monsuez JJ. Pericarditis associated with longstanding mesalazine administration in a patient. Int J Cardiol. 1999;68(2):243–5.
13. Doganay L, Akinci B, Pekel N, et al. Mesalazine-induced myopericarditis in a patient with ulcerative colitis. Int J Colorectal Dis. 2006 Mar;21(2):199–200.
14. Freeman HJ, Salh B. Recurrent myopericarditis with extensive ulcerative colitis. The Canadian journal of cardiology. 2010. p. 549–50.
15. Bernal-Sprekelsen JC, de las Marinas MD, Salvador A, et al. Recurrent pericarditis in a patient with ulcerative proctitis due to mesalazine suppositories. Int J Colorectal Dis. 2010 Sep;25(9):1143–4.
Related articles

Letter

Tofacitinib-induced eosinophilia

DOI: 10.17235/reed.2023.9831/2023

Letter

Perianal Paget’s disease

DOI: 10.17235/reed.2022.9304/2022

Letter

Chinese dragon sign of ulcerative colitis

DOI: 10.17235/reed.2022.9154/2022

Letter

Ulcerative colitis exacerbated by strongyloidiasis

DOI: 10.17235/reed.2022.9044/2022

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

Mesalazine induced interstitial pneumonitis in the COVID era

DOI: 10.17235/reed.2022.8635/2021

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Letter

Sweet syndrome in severe ulcerative flare

DOI: 10.17235/reed.2020.6995/2020

Letter to the Editor

Ulcerative colitis with gastric and duodenal involvement

DOI: 10.17235/reed.2017.4685/2016

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Citation tools
Bernardo S, Fernandes S, Araújo-Correia L. Mesalamine-induced myopericarditis - A case report. 4016/2015


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 926 visits.
This article has been downloaded 97 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 25/09/2015

Accepted: 29/09/2015

Online First: 15/02/2016

Published: 02/11/2016

Article revision time: 2 days

Article Online First time: 143 days

Article editing time: 404 days


Share
This article has been rated by 2 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology